Case Reports
Vol. 67 No. 4 (2015)
https://doi.org/10.4081/reumatismo.2015.856

Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 20 December 2015
Published: 23 May 2016
2556
Views
1034
Downloads
Vasculitis, rheumatology.
Internal Medicine

Authors

T. Aguiar
Department of Neurology, Clementine Fraga Filho University-Hospital, Federal University of Rio de Janeiro, Brazil.
M. B. Vincent
vincent@hucff.ufrj.br
Department of Neurology, Clementine Fraga Filho University-Hospital, Federal University of Rio de Janeiro, Brazil.
Giant cell arteritis (GCA), a systemic vasculitis of unknown origin, may appear rarely as a paraneoplastic syndrome. Cases secondary to pulmonary neuroendocrine tumors have not been reported. A 75-year-old female developed prednisone-responsive GCA/polymyalgia rheumatica (PMR) shortly followed by syndrome of inappropriate antidiuretic hormone secretion. An 8 mm carcinoid lung tumor with positron emission tomography normal uptake was found. After a thoracoscopic tumor resection the patient experienced complete clinical and laboratory remission. This is the first report of GCA with PMR in the context of carcinoid lung tumor. It emphasizes the role of paraneoplastic vasculitis as a possible cause of GCA.

Downloads

Download data is not yet available.

How to Cite



1.
Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor. Reumatismo [Internet]. 2016 May 23 [cited 2026 Aug. 22];67(4):165-8. Available from: https://www.reumatismo.org/reuma/article/view/856

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.